| scholarly article | Q13442814 |
| P2093 | author name string | Sun Sik Bae | |
| Ji Hyun Kim | |||
| Ki Whan Hong | |||
| Byung Tae Choi | |||
| Hwa Kyoung Shin | |||
| Yong-Il Shin | |||
| P2860 | cites work | Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke | Q24646522 |
| Pathobiology of ischaemic stroke: an integrated view | Q28141682 | ||
| Ex vivo lipopolysaccharide-induced interleukin-1 secretion from murine peritoneal macrophages inhibited by probucol, a hypocholesterolemic agent with antioxidant properties | Q28334440 | ||
| Update of the stroke therapy academic industry roundtable preclinical recommendations | Q29615508 | ||
| Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. | Q34118817 | ||
| Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction | Q34365500 | ||
| The vascular effects of cilostazol | Q36405138 | ||
| MCP-1 protects mice in lethal endotoxemia | Q37368530 | ||
| Cholesterol oxidation products and disease: an emerging topic of interest in medicinal chemistry. | Q37387429 | ||
| Synergistic efficacy of concurrent treatment with cilostazol and probucol on the suppression of reactive oxygen species and inflammatory markers in cultured human coronary artery endothelial cells | Q37459012 | ||
| Where are we with probucol: a new life for an old drug? | Q37490346 | ||
| Diet-induced obesity causes cerebral vessel remodeling and increases the damage caused by ischemic stroke | Q37648333 | ||
| Oxysterol derivatives of cholesterol in neurodegenerative disorders | Q37856338 | ||
| Stroke and the immune system: from pathophysiology to new therapeutic strategies | Q37867782 | ||
| Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender | Q39128180 | ||
| Obesity increases blood pressure, cerebral vascular remodeling, and severity of stroke in the Zucker rat. | Q39647425 | ||
| Microglial activation in the hippocampus of hypercholesterolemic rabbits occurs independent of increased amyloid production | Q40016454 | ||
| Risk factor profile and management of cerebrovascular patients in the REACH Registry | Q40114179 | ||
| Cilostazol reduces atherosclerosis by inhibition of superoxide and tumor necrosis factor-alpha formation in low-density lipoprotein receptor-null mice fed high cholesterol. | Q40453919 | ||
| Probucol as an antioxidant and antiatherogenic drug | Q40887005 | ||
| Hypertension and stroke. | Q41446999 | ||
| High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice. | Q41881815 | ||
| Influence of hypercholesterolemia and hypertension on the integrity of the blood-brain barrier in rats | Q43239573 | ||
| Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. | Q44015016 | ||
| Combinatorial effect of probucol and cilostazol in focal ischemic mice with hypercholesterolemia | Q44808585 | ||
| The epidemiology of overweight and obesity: public health crisis or moral panic? | Q44947045 | ||
| LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms. | Q46019644 | ||
| Antiatherogenic effects of cilostazol and probucol alone, and in combination in low density lipoprotein receptor-deficient mice fed with a high fat diet | Q46650594 | ||
| High cholesterol diet results in increased expression of interleukin-6 and caspase-1 in the brain of apolipoprotein E knockout and wild type mice | Q46730918 | ||
| Neuroprotection by cilostazol, a phosphodiesterase type 3 inhibitor, against apoptotic white matter changes in rat after chronic cerebral hypoperfusion | Q46974633 | ||
| Beneficial synergistic effects of concurrent treatment with cilostazol and probucol against focal cerebral ischemic injury in rats | Q48158533 | ||
| Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells | Q48285984 | ||
| Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats | Q48365404 | ||
| Brain cytokine synthesis induced by an intraparenchymal injection of LPS is reduced in MCP-1-deficient mice prior to leucocyte recruitment | Q48457563 | ||
| Behavioral tests after intracerebral hemorrhage in the rat. | Q48475050 | ||
| Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model | Q48663782 | ||
| Trends in stroke hospitalizations and associated risk factors among children and young adults, 1995-2008. | Q48913040 | ||
| Salvianolic acid B attenuates brain damage and inflammation after traumatic brain injury in mice. | Q51028188 | ||
| Type 2 Diabetes Mellitus and Insulin Resistance: Stroke Prevention and Management. | Q51527048 | ||
| Probucol attenuates inflammation and increases stability of vulnerable atherosclerotic plaques in rabbits. | Q52615374 | ||
| Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. II. Cellular composition and proliferation. | Q54161571 | ||
| Effects of Cerebral Ischemia in Mice Deficient in Neuronal Nitric Oxide Synthase | Q71647466 | ||
| ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree | Q72689998 | ||
| Differential induction of chemokines in human microglia by type I and II interferons | Q73372530 | ||
| Probucol [4,4'-[(1-methylethylidene)bis(thio)]bis-[2,6-bis(1,1-dimethylethyl)phenol]] inhibits compensatory remodeling and promotes lumen loss associated with atherosclerosis in apolipoprotein E-deficient mice | Q79758392 | ||
| P433 | issue | 3 | |
| P921 | main subject | hypercholesterolemia | Q762713 |
| P304 | page(s) | 687-694 | |
| P577 | publication date | 2014-07-10 | |
| P1433 | published in | International Journal of Molecular Medicine | Q6051492 |
| P1476 | title | Probucol plus cilostazol attenuate hypercholesterolemia‑induced exacerbation in ischemic brain injury via anti-inflammatory effects | |
| P478 | volume | 34 |
| Q37151611 | Probucol inhibits LPS-induced microglia activation and ameliorates brain ischemic injury in normal and hyperlipidemic mice |
| Q36530909 | Synergistic Effects of Cilostazol and Probucol on ER Stress-Induced Hepatic Steatosis via Heme Oxygenase-1-Dependent Activation of Mitochondrial Biogenesis |
Search more.